| | Main Menu | Back to Activity by Object - FY 2026 | |
Activity for Object 7986 - Unexpended Cash Balance Forward-- Operating Transfers Out
Fund 5136 - GR Account - Cancer Prevention and Research
Fiscal Year 2026 activity September 1, 2025 - April 30, 2026
Prior fiscal years September 1 - August 31
| Fiscal Year | Revenue | Expenditures | Net Activity | |
|---|---|---|---|---|
 |
2026 | 0.00 | 903,021.95 | (903,021.95) |
|
2025 | 0.00 | 872,521.95 | (872,521.95) |
|
2024 | 0.00 | 1,636,419.45 | (1,636,419.45) |
|
2023 | 0.00 | 584,764.45 | (584,764.45) |
|
2022 | 0.00 | 985,128.90 | (985,128.90) |
|
2021 | 0.00 | 47,600.00 | (47,600.00) |
|
2020 | 0.00 | 492,564.45 | (492,564.45) |
|
2019 | 0.00 | 985,164.48 | (985,164.48) |
|
2017 | 0.00 | 1,563,186.19 | (1,563,186.19) |
|
2016 | 0.00 | 1,288,961.19 | (1,288,961.19) |
|
2015 | 0.00 | 238,847.00 | (238,847.00) |
|
2014 | 0.00 | 15,229.83 | (15,229.83) |
|
2011 | 0.00 | 16,873.79 | (16,873.79) |